BriaCell Secures $2.05 Million NCI Grant to Advance Bria-PROS+™ Immunotherapy in Metastatic Prostate Cancer

  US$2,054,651 non-dilutive grant from the US National Cancer Institute to complete manufacturing of Bria-Pros+TM clinical supply and support Phase...

August 26, 2025 | Tuesday | News
BlossomHill Therapeutics Doses First Patient in SOLARA Trial Expansion of First-in-Class OMNI-EGFR™ Inhibitor

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines ...

August 25, 2025 | Monday | News
Stanford’s ViRx and Fifty1 AI Labs Forge Alliance to Repurpose Drugs for Pandemic Preparedness

ViRx@Stanford, a leading biosecurity and pandemic preparedness initiative, and Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), an innovati...

August 25, 2025 | Monday | News
PathAI and Moffitt Cancer Center Launch Strategic Collaboration to Shape the Future of Cancer Care

PathAI, a global leader in artificial intelligence and digital pathology solutions, and Moffitt Cancer Center, one of the nation’s top cancer hospi...

August 22, 2025 | Friday | News
Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in EU Unified Patent Court Over Paxlovid™

-Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infectio...

August 21, 2025 | Thursday | News
RemeGen and Santen Forge Strategic Alliance to Advance RC28-E for Retinal Diseases Across Asia

RemeGen Co., Ltd, a leading Chinese biopharmaceutical company, announced today that it has entered into an agreement with Santen Pharmaceutical (China) C...

August 19, 2025 | Tuesday | News
Atropos Health and Novartis Partner to Harness AI for Faster Rare Disease Diagnosis

-Atropos Health, a leader in translating real-world clinical data into personalized real-world evidence (RWE) and insights, announced a collaboration wit...

August 19, 2025 | Tuesday | News
European Commission Approves OGSIVEO® as First-Ever Therapy for Desmoid Tumours

SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced that the European Commission (EC) granted marketing aut...

August 19, 2025 | Tuesday | Regulatory
Philips Commits $150M+ to U.S. Manufacturing and R&D, Expanding AI-Enabled Healthcare Capabilities

    Philips, a global leader in health technology,announced a plan for new investments of more than USD 150 million in U.S. manufacturi...

August 15, 2025 | Friday | News
Insmed Secures FDA Approval for BRINSUPRI™, the First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis

Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung D...

August 14, 2025 | Thursday | News
Amalgam Secures $20M Credit Investment from Catalio Capital to Accelerate Medical-Grade AI Expansion

 announced a $20 million credit investment from Catalio Capital Management, a leading investment firm dedicated to backing innovative healthcare com...

August 13, 2025 | Wednesday | News
Dräger’s Atlan A350/A350XL Anesthesia Workstations Achieve U.S. DoD ATO Certification for Maximum Patient Data Security

Certification ensures highest level of patient data security a medical device can attain Effective 7/14/2025 and expiring on 7/14/2028 under eMASS ...

August 12, 2025 | Tuesday | News
Fosun Pharma Grants Global Rights (Ex-China) for Innovative Respiratory Drug XH-S004 to Expedition Therapeutics

Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics ...

August 12, 2025 | Tuesday | News
Nyxoah Secures FDA Approval for Genio System to Treat Moderate to Severe Obstructive Sleep Apnea

Nyxoah SA , a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, ann...

August 11, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close